Two decades of experience with modified Heller's myotomy for achalasia

We reviewed the hospital records of 36 patients who underwent modified Heller's myotomy for achalasia between January, 1961, and December, 1982. There were 18 male and 18 female patients ranging between 17 months and 75 years old. The most frequent symptom was dysphagia, followed by regurgitation of ingested food and weight loss. Modified Heller's myotomy was performed through a transthoracic incision in 35 patients and a transabdominal incision in 1. An antireflux procedure in addition to esophagomyotomy was performed in 20 patients. There was 1 postoperative death. Thirty-three patients were followed up for periods ranging from 9 months to 21 years. The results were considered good in 27, fair in 2, and poor in 4. One of the 4 underwent repeat esophagomyotomy 71/2 years after the initial operation with a good result. The remaining 3 had an antireflux procedure at the time of esophagomyotomy. Because of recurrence of symptoms, esophagogastrostomy was performed in 1 and colon interposition in 2. These results suggest that an antireflux procedure should not be added to modified Heller's operation in the treatment of achalasia.     

Clinical experience with a porcine aortic valve xenograft for mitral valve replacement

Between March, 1971, and July, 1973, 103 patients underwent mitral valve replacement with a glutaraldehyde-preserved porcine aortic valve mounted on a flexible polypropylene, Dacron-covered stent. Overall operative survival was 95.1%. Actuarial analysis of late postoperative results indicates 92% survival through 2 years, with functional improvement in nearly all patients. The rate of systemic thromboembolism has been approximately 1.7% per patient-year without anticoagulants. No valve failure has occurred. We conclude that this xenograft prosthesis provides a technically and functionally satisfactory valve substitute, the durability of which appears to significantly exceed that of previously available tissue valves for mitral replacement.     

Mitral valve replacement with viable aortic homograft valves

Forty consecutive patients underwent mitral valve replacement with viable aortic valve homografts. Viability was assessed by autoradiography in a sample of the aortic wall of the graft at the time of insertion. Sixty to 75% of the fibroblasts were found to be metabolically active.All patients were in New York Heart Association Functional Class III or IV prior to operation. Pulmonary hypertension was present in 37. One patient died in the hospital, and 1 late death occurred 9 months postoperatively. Anticoagulants were discontinued 6 weeks after operation without thromboembolic complications. Thirty-six of the patients showed marked clinical improvement, and only 3 patients were found to have a mild degree of mitral regurgitation by angiography.This experience has encouraged us to continue with this method of mitral valve replacement.     

Free-floating ball thrombus in the left atrium after mitral valve replacement: successful surgical management

A free-floating ball thrombus in the left atrium is a rare clinical problem with potentially catastrophic consequences. Thus, early diagnosis and prompt surgical intervention are mandatory. Free ball-valve thrombus within the left atrium developed in a patient who had undergone mitral valve replacement with a Starr-Edwards prosthesis seven years previously. The diagnosis was accurately made by two-dimensional echocardiography and was followed by successful removal of a thrombus. A review of the literature is presented.     

Risks of mitral valve replacement and mitral valve replacement with coronary artery bypass

One hundred thirty consecutive patients who underwent mitral valve replacement (MVR) or MVR with coronary artery bypass grafting (CABG) using cold crystalloid cardioplegic solution were analyzed to determine operative mortality and risk factors. Twenty-eight patients had mitral stenosis (MS), 37 had mitral regurgitation (MR), 37 had mixed MS and MR, 23 had MR with coronary artery disease (CAD), and 5 had MS with CAD. Preoperative pulmonary artery pressure, pulmonary capillary wedge pressure, and cardiac index were not different among groups, but patients with MR and CAD had a significantly higher left ventricular end-diastolic pressure (LVEDP) and a significantly lower ejection fraction than other groups. Mortality was 7.1% for patients with MS, 5.4% for MR, 8.1% for mixed MS and MR, 0 for MS with CAD, and 21.7% for MR and CAD. Overall mortality was 9.2%. Eleven patients had emergency operations for cardiogenic shock with a mortality of 45%. Nineteen additional patients in New York Heart Association (NYHA) Functional Class IV had MVR or MVR plus CABG with a mortality of 26%. Sixteen patients required intraaortic balloon pump assistance, and 9 survived. Four patients with MR and CAD required the left ventricular assist device, and 3 survived. Excluding patients who had emergency operations, overall mortality was 5.8%. Excluding patients who had emergency operations and patients in NYHA Functional Class IV, overall mortality was 2%. Factors associated with death were cardiogenic shock, NYHA Class IV, LVEDP greater than 15 mm Hg (16% mortality), and age greater than 60 years (15% mortality).     

Caustic ingestion and subsequent damage to the oropharyngeal and digestive passages.

The characteristics, diagnosis, and management of oropharyngeal and digestive passage lesions due to ingestion of caustic agents are presented. Previous experimental and clinical studies are reviewed with discussion of the peculiar qualities of the newer caustics. Differentiation in treatment of burns caused by solid and liquid agents is stressed.     

Posterior midventricular rupture after mitral valve replacement.

Posterior midventricular rupture occurred in 3 patients after insertion of a mitral prosthesis. Iatrogenic surgical trauma was not implicated. There were five clinical factors common to each case: a woman with mitral stenosis; a left ventricle of relatively normal size; the use of intermitent cold cardioplegia; the insertion of a porcine heterograft valve; and transient postoperative hypertension. Rupture in such cases may be caused by hyperdynamic left ventricular contraction against the strut of the prosthesis. Causes of ventricular perforation are discussed.     

Myocardial protection during aortic valve replacement.

The results following aortic valve replacement (AVR) were compared in 40 patients in whom the myocardium was protected by topical hypothermic arrest or continuous coronary perfusion with sustained electrical fibrillation (Group A) and 40 similar patients in whom the hearts were also continuously perfused but were kept in the beating state (Group B). The operative mortality was not greatly different between the two groups, being 10 and 5%, respectively. The postperfusion cardiac performance was strikingly different, however. Seventeen patients (43%) in Group A required inotropic support, while this was necessary in only 1 patient (3%) in Group B. In this instance, recurrent ventricular fibrillation persisted despite attempts at reversion. These data show that the myocardium is preserved best during AVR when continuous coronary perfusion is used and the heart is maintained in the beating state.     

Aortic insufficiency requiring valve replacement in Whipple's disease.

Reviews of postmortem reports on patients with Whipple's disease (intestinal lipodystrophy) describe gross valvular deformity in more than 50% with characteristic histological findings of macrophages containing periodic acid-Schiff-positive, diastase-resistant granules. Frequently, congestive heart failure characterizes the terminal stages. In a 58-year-old man with well-documented Whipple's disease for 5 years, gastrointestinal, joint, and pericardial involvement apparently resolved with medical therapy. However, 10 years later, severe aortic insufficiency necessitated prosthetic valve replacement, at which time gross and histological examination of the excised valve demonstrated characteristic changes of Whipple's disease. Clinical recognition of the importance of cardiac valvular abnormalities and of possible late cardiac decompensation mandates close observation of patients with Whipple's disease. Corrective operation should improve the patient's chances of survival.     

Intraoperative posterior left ventricular wall rupture associated with mitral valve replacement.

An unusual but often lethal complication of mitral valve replacement is rupture of the left ventricle. The two recognized types of rupture are discussed, and the literature and pathology are reviewed. It is stressed that this complication can be prevented, and the factors involved in prevention are outlined.     

Aortic and mitral valve replacement with cloth-covered Braunwald-Cutter prosthesis. A three-year follow-up.

From February, 1971, through February, 1974, heart valves of 510 patients were replaced with cloth-covered Braunwald-Cutter prostheses. The data indicate that cloth encapsulation of the prosthetic cage is associated with a reduction in thromboembolic complications, particularly for mitral valves. Cloth wear on the distal strut, however, is not prevented by use of a Silastic poppet and appears to be a typical finding in aortic valves recovered or inspected after 3 months. Excessive poppet wear has also been noted in the aortic position; poppet embolization has occurred on 2 occasions, and a third patient was found, at the time of reoperation for periprosthetic leak, to have opppet wear sufficient to permit embolization. Although there have been no reports of clinical malfunction of the mitral prosthesis at the time of this writing, further long-term observation of these patients appears warranted.     

Thromboembolism after Beall Valve replacement of the mitral valve.

A series of 76 isolated mitral valve replacements with the Beall valve is reported. A perioperative mortality of 3.5% (3 patients) and a late mortality of 6.8% (5 patients) was obtained. Thromboembolism occurred in 4 patients (5.2%). In a separate study, platelet survival times were determined in 17 patients with Beall valves by using chromium 51–labeled autologous platelets. Six patients had had thromboembolic (TE) episodes; the remaining 11 had not. The normal platelet survival time was > 3.3 days. Patients with TE had shortened platelet survival times (mean 2.8 $pM 0.11 days) which were significantly less (p < 0.01) than those of patients without TE (mean 3.4 $pM 0.13 days). The incidence of TE, which is associated with shortened platelet survival time, is low with Beall mitral valves. Prognostic and therapeutic considerations are discussed.     

Patient-related risk factors as predictors of results following isolated mitral valve replacement

Results following isolated mitral valve replacement in 897 consecutive patients over a twelve-year period were analyzed with regard to the influence of various preoperative patient-related risk factors. Actuarial data analysis allowed definition of major preoperative, etiological, clinical, and hemodynamic correlates to both perioperative and long-term postoperative patient survival. Patient age below 60 years, preoperative New York Heart Association Functional Class of III or less, cardiac index greater than 2.0, and left ventricular end-diastolic pressure of less than 12 mm Hg were all highly significant correlates of improved perioperative as well as long-term patient survival. Patients whose predominant functional lesion was mitral insufficiency had only a 53% five-year survival (187 of 352 patients) following mitral valve replacement as opposed to 70% (521 of 745 patients) for those who had mixed or stenotic mitral lesions. Primary ischemic mitral dysfunction was associated with only 31% five-year survival (17 of 54 patients) after mitral valve replacement in contrast to 69% (480 of 695 patients) for patients with rheumatic mitral lesions. The presence of occlusive coronary artery disease coexisting with, but not the primary cause of, mitral dysfunction was associated with decreased perioperative and late postoperative survival. Results support both earlier operative intervention and wider use of associated procedures, ie, coronary bypass grafting, with mitral valve replacement. Recognition of major preoperative patient-related risk factors should enhance survival following this procedure.     

Testing of mitral valve competence following combined mitral valve repair and aortic valve replacement

A simple, effective technique for testing the results of repair and reconstructive procedures on the mitral valve apparatus is described. This technique can be used in the operative setting of combined aortic valve replacement and mitral valve repair where other reported techniques for testing the valve apparatus are rendered unfeasible.     

Late clinical problems with Beall model 103 and 104 mitral valve prostheses: hemolysis and valve wear.

The purpose of this study was to determine the influence on hemolysis of the spatial orientation of the struts in the Beall mitral valve prosthesis, Models 103 and 104. Thirteen pairs of patients were selected to match struts oriented parallel and perpendicular to the left ventricular outflow tract axis. The average time after operation was 3.73 years. Complete blood counts and relative serum chemistry values were determined.     

Clinical experience with an improved mitral valve prosthesis

More than five years ago a Dacron velour-covered Teflon-disc mitral valve prosthesis was introduced in an effort to decrease thromboembolic complications of mitral valve replacement. Numerous reports have demonstrated an extremely low incidence of thromboembolic complications with this prosthesis. Efforts toward improving the prosthesis have been aimed at using more durable materials, and a Dacron velour-covered mitral prosthesis using Pyrolite carbon for both the disc and the cage legs now is available. Animal investigations with scanning electron microscopical wear analysis predicted 140 years of wear prior to penetration of the Pyrolite carbon coating. Clinical trials then were begun, and combined experience with this prosthesis in three centers now includes 175 cases. There have been no deaths related to the prosthesis, and only four thromboembolic episodes have occurred; the only fatal one was an embolus from the left atrial appendage that occluded the prosthesis. This improved prosthesis appears to offer significant advantages.     

The results of valve replacement for mitral valve prolapse

Between January, 1975, and December, 1982, 33 patients underwent mitral valve replacement for mitral valve prolapse secondary to myxomatous degeneration. The majority were in the seventh decade of life (median age, 62 years), and all were seen with symptoms of mitral regurgitation. Echocardiography was more accurate in making the diagnosis of mitral valve prolapse more often (75%) than angiography (66%). Thirty-eight percent of the patients who underwent cineangiography had concomitant coronary artery disease and had coronary artery bypass grafting as well as mitral valve replacement. There was 1 operative death, an operative mortality of 3%. There were 6 late deaths, a late mortality of 18%. Of the 26 long-term survivors, 23 (88%) were in New York Heart Association Functional Class I and 3 (12%) were in Class II. The average length of follow-up was 33.25 months, and the 5-year actuarial survival was 76%. There was only one incident of thromboembolism (3%). Short-term and long-term survival were not related to the severity of mitral regurgitation but to the status of the left ventricle and the overall condition of the patient. These data suggest that older patients with severe mitral regurgitation secondary to mitral valve prolapse can undergo valve replacement with low operative mortality and gratifying long-term results.     

A continuous suture technique for mitral valve replacement

The use of continuous suturing in mitral valve replacement is discussed. Because of its advantages, the technique merits more widespread use.     

Reconstruction of the mitral valve

Isolated mitral valve reconstruction was performed in 100 consecutive patients for either mitral regurgitation or combined mitral valve disease. Early mortality was 8% for the total series but has decreased to 2% since 1965. Eight late deaths occurred between 2 and 99 months after operation.Preoperatively all but 2 patients were in Functional Class III or IV according to the New York Heart Association classification. One to two years after operation 72 patients were ameliorated by one to three functional classes and 7 were unchanged. Four to nine years postoperatively 28 were still improved by one to three functional classes while 3 were the same as preoperatively, and 5 patients had died during this late follow-up period.Objective assessment of postoperative mitral valve function by apnea curves and dye-dilution curves yielded good long-term results. Postoperative cardiac catheterization studies demonstrated a marked decrease in pulmonary artery and pulmonary capillary wedge pressures. Six patients had to be reoperated upon because of either progressing rheumatic disease or unsatisfactory repair. Analysis of actuarial survival curves demonstrates more favorable results with mitral valve reconstruction than with mitral valve replacement in comparable series, primarily because of the low embolus rate after reconstruction.     

Combined multiple-valve procedures: a five-year experience with 125 patients.

One hundred twenty-five patients underwent 128 operations for combined multiple-valve procedures, with an overall early mortality of 16%. Highest mortality was associated with mitral and tricuspid valve disease (28.5%), followed by triple-valve disease (18.2%) and aortic and mitral valve disease (14%). Left ventricular end-diastolic pressure, cardiac index, mean pulmonary artery pressure, pulmonary artery wedge pressure, and arteriovenous oxygen difference were all significantly different in patients with regard to early mortality. Late follow-up of 94% has been achieved in 105 early survivors, with a late mortality rate of 11.2%. Analysis of late functional results reveal that 85% of survivors improved at least one Functional Class. Actuarial 5-year survival of 75% was achieved for early survivors of operation.